Fallas terapéuticas en el tratamiento de la giardiosis

Authors

Abstract

Editorial donde se visualiza lo frecuente de la giardiosis resistente a 5- nitroimidazólicos y las alternativas para su manejo terapéutico.

Downloads

Download data is not yet available.

Author Biography

Roberto Cañete Villafranca, Dirección de Salud Pública - Universidad de Ciencias Médicas de Matanzas.

Director of the Council for Scientific Societies of Health in Matanzas.

References

Cañete R, Brito K, Brito I, Semper A, Gonzalez ME. Effectiveness and Tolerability of 3-Day Mebendazole Treatment of Giardia duodenalis Infection in Adults and Children: Two Prospective, Open-Label Phase IV Trials. Curr Ther Res Clin Exp. 2018;89:43- 7. https://doi:10.1016/j.curtheres.2018.11.002.

Nabarro LE, Lever RA, Armstrong M, Chiodini PL. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013. Clin Microbiol Infect. 2018;21:791- 6. https://doi:10.1016/j.cmi.2015.04.019.

Cañete R, Noda AL, Rodríguez M, Brito K, Herrera E, Poul-Erik Kofoed, Ursing J. 5-nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study. Clinical Microbiology and Infection. 2020;26(8):1092.e1-1092.e6. https://doi.org/10.1016/j.cmi.2019.12.017.

Published

2024-06-17

How to Cite

1.
Cañete Villafranca R. Fallas terapéuticas en el tratamiento de la giardiosis. Arch.cuba.gastroenterol. [Internet]. 2024 Jun. 17 [cited 2025 Mar. 14];3:e139. Available from: https://revgastro.sld.cu/index.php/gast/article/view/139